Insider Selling: Trupanion (NASDAQ:TRUP) COO Sells 3,604 Shares

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 3,604 shares of the stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $29.70, for a total value of $107,038.80. Following the transaction, the chief operating officer owned 33,742 shares in the company, valued at $1,002,137.40. This trade represents a 9.65% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trupanion Price Performance

NASDAQ TRUP traded down $1.27 on Tuesday, hitting $27.88. The company had a trading volume of 400,520 shares, compared to its average volume of 630,232. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The company’s fifty day moving average price is $27.21 and its 200-day moving average price is $25.89. The company has a market capitalization of $1.22 billion, a PE ratio of 52.60, a PEG ratio of 1.97 and a beta of 1.45. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $46.98.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The business had revenue of $392.93 million for the quarter, compared to the consensus estimate of $389.72 million. During the same period last year, the firm posted $0.22 earnings per share. The company’s revenue was up 11.1% compared to the same quarter last year. As a group, analysts predict that Trupanion, Inc. will post 0.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on TRUP. Atlantic Securities set a $42.00 target price on shares of Trupanion in a research note on Wednesday, July 15th. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Weiss Ratings raised shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, August 26th. Stifel Nicolaus lifted their target price on shares of Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. Finally, Piper Sandler lowered Trupanion from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Trupanion presently has a consensus rating of “Hold” and an average price target of $39.20.

Hedge Funds Weigh In On Trupanion

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Kelleher Financial Advisors purchased a new stake in Trupanion during the 2nd quarter valued at approximately $42,000. Parallel Advisors LLC grew its position in Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after buying an additional 1,722 shares during the last quarter. Kemnay Advisory Services Inc. acquired a new position in Trupanion in the 4th quarter valued at $64,000. Quantbot Technologies LP purchased a new stake in shares of Trupanion in the second quarter valued at about $89,000. Finally, Advisory Services Network LLC acquired a new position in Trupanion during the 3rd quarter worth approximately $160,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.